Syneos Health, Inc. provided earnings guidance for the third quarter of 2022. For the period, the company expects third quarter revenue of $1.365 billion to $1.395 billion. This reflects as-reported revenue growth of 1.2% to 3.5% compared to the third quarter of 2021.

Excluding reimbursable expenses and on a constant currency basis, this reflects expected revenue growth of approximately 12.6% compared to the third quarter of 2021. This revenue growth includes an estimated contribution from acquisitions of approximately 90 basis points and expected foreign exchange headwind of $37 million and an expected headwind of approximately 770 basis points due to reimbursable expenses.